EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring recent insights on intermittent fasting in regulating glucocorticoid levels and diet-induced metabolic disorders with focus on MAFLD and hepatic outcomes

Jasper Okoro Godwin Elechi, Carolina Ramos de Mendonça, Vitor Carlos de Araújo Bandeira, Maria Surama Pereira Da Silva, Ana Paula Rocha de Melo, Rubem Carlos Araujo Guedes, Sandro Massao Hirabara, Erika Cione, Diogo Antonio Alves de Vasconcelos

Molecular and Cellular Endocrinology · 2026

DOI: 10.1016/j.mce.2026.112736 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular and Cellular Endocrinology, 2026. Verfasst von Jasper Okoro Godwin Elechi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Nutrition, Department of Nutrition, Federal University of Pernambuco (UFPE), 50731-250, Recife, PE, Brazil; Department of Pha…. Hauptthemen laut MEDLINE: Glucocorticoids, Intermittent Fasting, Non-alcoholic Fatty Liver Disease, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Consumers' risky eating behaviours aided by the current food environment have led to an increase in diet-related metabolic disorders. Metabolic (dysfunction)-associated fatty liver disease origin represents a major global health burden that is increasing at an alarming rate on an annual basis. Modifying the timing of calorie consumption, dietary composition, or caloric intake offers a promising therapeutic approach for the management of this condition. The aim of this review was to provide a concise analysis of the impact of intermittent fasting on the regulation of glucocorticoid levels and diet-induced metabolic disorders with a focus on non-alcoholic fatty liver diseases. We found that intermittent fasting primarily regulates hepatic autophagy via nutritional and hormonal pathways, aiding in the maintenance of energy equilibrium, enhancement of mitochondrial function, regulation of liver quality, preservation of cellular homeostasis, protection of cells from harmful factors, mitigation of liver metabolic disorders, and improvement of liver inflammation. Also, the physiological changes induced by intermittent fasting and their metabolic consequences arise through multiple mechanisms, including alterations in hepatic metabolism, hepatic autophagy, inflammatory responses, liver functional enzymes, hepatic steatosis, fibroblast growth factor signalling, White adipoe tissue browning, adipokines, circadian rhythms, lipid profiles, body composition, the adipose tissue-gut microbiome axis, skeletal muscle, and the autophagy process. Interestingly, we identified the complex interplay among glucocorticoids, intermittent fasting, and non-alcoholic fatty liver diseases highlighting the hepatic macrophage glucocorticoid receptor as a pivotal mediator of fasting-induced reprogramming of the macrophage secretome, including fasting-suppressed cytokines. In conclusion, existing data indicates that intermittent fasting in patients with non-alcoholic fatty liver diseases is a viable, safe, and successful strategy for weight reduction, demonstrating notable trends in the amelioration of dyslipidaemia and non-alcoholic fatty liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsIntermittent FastingNon-alcoholic Fatty Liver DiseaseLiverDietMetabolic DiseasesFastingHumansAnimalsAutophagy

Stichwörter der Autor:innen

Circadian rhythmCirrhosisEnergy metabolismFatty liverInsulin resistanceLipid metabolismMetabolic syndromeObesityTime-restricted feeding

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Postgraduate Program in Nutrition, Department of Nutrition, Federal University of Pernambuco (UFPE), 50731-250, Recife, PE, Brazil; Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, 870…
  • Postgraduate Program in Nutrition, Department of Nutrition, Federal University of Pernambuco (UFPE), 50731-250, Recife, PE, Brazil. Electronic address: carolina.ramosmendonca@ufpe.br.
  • Multicentric Postgraduate Program in Physiological Sciences - CAV, Federal University of Pernambuco (UFPE), Vitória de Santo Antão, Brazil.
  • Postgraduate Program in Nutrition, Department of Nutrition, Federal University of Pernambuco (UFPE), 50731-250, Recife, PE, Brazil.
  • Interdisciplinary Post-graduate Program in Health Sciences, Cruzeiro do Sul University, São Paulo, Brazil.
  • Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy.

Zitieren

APA

Elechi, J. O. G., de Mendonça, C. R., Bandeira, V. C. A., Da Silva, M. S. P., de Melo, A. P. R., Guedes, R. C. A., Hirabara, S. M., Cione, E., & de Vasconcelos, D. A. A. (2026). Exploring recent insights on intermittent fasting in regulating glucocorticoid levels and diet-induced metabolic disorders with focus on MAFLD and hepatic outcomes. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2026.112736

Vancouver

Elechi JOG, de Mendonça CR, Bandeira VCA, Da Silva MSP, de Melo APR, Guedes RCA, et al. Exploring recent insights on intermittent fasting in regulating glucocorticoid levels and diet-induced metabolic disorders with focus on MAFLD and hepatic outcomes. Molecular and Cellular Endocrinology. 2026. doi:10.1016/j.mce.2026.112736

BibTeX
@article{Elechi2026,
  author = {Elechi, Jasper Okoro Godwin and de Mendonça, Carolina Ramos and Bandeira, Vitor Carlos de Araújo and Da Silva, Maria Surama Pereira and de Melo, Ana Paula Rocha and Guedes, Rubem Carlos Araujo and Hirabara, Sandro Massao and Cione, Erika and de Vasconcelos, Diogo Antonio Alves},
  title = {Exploring recent insights on intermittent fasting in regulating glucocorticoid levels and diet-induced metabolic disorders with focus on MAFLD and hepatic outcomes},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  doi = {10.1016/j.mce.2026.112736}
}
Kostenlos starten →